newsfilter
← Latest News
GlobeNewswire·

LexaGene Expands Bio-Pharma Contamination Panel by Adding Test that includes a Biothreat Agent

BEVERLY, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, today announced it has success